Cannabidiol, or CBD, is one of the two common compounds found in marijuana, the other being THC. Unlike THC, which is a psychoactive compound, CBD is a nonpsychoactive compound. These compounds can be derived directly from the hemp plant or manufactured in a lab. Research has shown that CBD holds the potential for the treatment of various conditions, including post-traumatic stress disorder, depression and anxiety.
It also possesses anti-inflammatory and antibacterial properties, which can help control various skin issues that commonly affect skin. Its anti-inflammatory properties in particular can be used to treat different skin illnesses. Some consumers prefer using CBD skincare products instead of other skincare and beauty products in the market. Below are some of the benefits one can derive from using CBD for skin inflammation.
CBD can be used to manage acne
Acne is a common inflammatory condition that affects individuals across the globe. It can cause redness and puffiness in an individual’s face, among other things.
CBD can help control acne by managing the redness, puffiness and inflammation associated with this common skin condition. This means that it’s possible for individuals affected with acne to keep their skin healthy and clear using CBD.
CBD can manage inflammation caused by aging
Inflammation is one of the signs of aging that can be seen in individuals. Inflammation is mainly brought about by the accumulation of free radicals on the skin in a process known as oxidative stress.
CBD’s excellent antioxidant properties can be used to control the inflammation caused by oxidative stress, which will in turn help reduce the visible signs of aging on an individual’s skin. This means that CBD skincare products can be used to keep an individual’s skin healthy, young and glowing.
In addition, CBD can also help control various skin diseases such as acne and psoriasis, which means that CBD skincare products can help manage different skin diseases naturally.
CBD can reduce inflammation caused by psoriasis
Psoriasis is a skin disease that causes itchy, scaly and red patches on the scalp, trunk, elbows and knees of an individual. This disease causes difficulties in individuals who suffer from this condition. CBD may help control this skin disease by reducing the inflammation associated with psoriasis and related disorders. CBD has also demonstrated its potential in reducing other symptoms associated with psoriasis, such as pain, swelling and scaly patches.
Companies such as Flora Growth Corp. (NASDAQ: FLGC) are leveraging the anti-inflammatory attributes of CBD by including this cannabinoid in the formulation of their beauty products, and from the way these products are growing in popularity, consumers seem to be receiving value for their money.
NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
